Nicola Cresti (N Cresti)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Nature communications

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ruth P Norris, Rosie Dew, Alastair P Greystoke, Nicola Cresti, Henry Cain, Adam Todd, Linda Sharp
Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An English population-based study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Ruth P Norris, Rosie Dew, Alastair P Greystoke, Nicola Cresti, Henry Cain, Adam Todd, Linda Sharp
Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An English population-based study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, Michael J Seckl
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 13 (1) (2022)
Rebecca H Maier, Chris Plummer, Adetayo Safiriyu Kasim, Nasima Akhter, Emmanuel Ogundimu, Jamie M Maddox, Janine Graham, Michael Stewart, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Mark Verrill, Richard Graham, Lisa Chang, Helen C Hancock, David Austin
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT). BMJ open 12 (12) (2022)
Rebecca H Maier, Chris Plummer, Adetayo Safiriyu Kasim, Nasima Akhter, Emmanuel Ogundimu, Jamie M Maddox, Janine Graham, Michael Stewart, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Mark Verrill, Richard Graham, Lisa Chang, Helen C Hancock, David Austin
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT). BMJ open 12 (12) (2022)
Rebecca H Maier, Chris Plummer, Adetayo Safiriyu Kasim, Nasima Akhter, Emmanuel Ogundimu, Jamie M Maddox, Janine Graham, Michael Stewart, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Mark Verrill, Richard Graham, Lisa Chang, Helen C Hancock, David Austin
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT). BMJ open 12 (12) (2022)
Rebecca H Maier, Chris Plummer, Adetayo Safiriyu Kasim, Nasima Akhter, Emmanuel Ogundimu, Jamie M Maddox, Janine Graham, Michael Stewart, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Mark Verrill, Richard Graham, Lisa Chang, Helen C Hancock, David Austin
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT). BMJ open 12 (12) (2022)
Rebecca H Maier, Chris Plummer, Adetayo Safiriyu Kasim, Nasima Akhter, Emmanuel Ogundimu, Jamie M Maddox, Janine Graham, Michael Stewart, Andrew Wardley, Sophie Haney, Sharareh Vahabi, Helen Oxenham, Alison Humphreys, Nicola Cresti, Mark Verrill, Richard Graham, Lisa Chang, Helen C Hancock, David Austin
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT). BMJ open 12 (12) (2022)